NCT06673433

Brief Summary

The present study was designed to include obese patients diagnosed with obesity in the First Affiliated Hospital of Chongqing Medical University and a healthy control population. By analysing the relationship between metabolic parameters and macrogenomes in obesity, identifying key metabolic and macrogenomic differences between obese patients and healthy populations, and establishing the association between environmental factors and obesity-related metabolic disorders, the investigators will be able to provide new biomarkers and intervention targets for obesity prevention and treatment.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2022

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

November 2, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 4, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

June 2, 2025

Status Verified

November 1, 2024

Enrollment Period

2.8 years

First QC Date

November 2, 2024

Last Update Submit

May 28, 2025

Conditions

Keywords

obesityenvironmentair pollutionmacrogenomicsmetabolism

Outcome Measures

Primary Outcomes (1)

  • BMI

    BMI = weight / height squared (kg/m2)

    BMI was examed when first join the study, whith through the whole study period, an average of 1 month.

Study Arms (2)

the obesity group

Patients diagnosed with obesity (body mass index (BMI) ≥ 28kg/m2)

Diagnostic Test: obesity

the control group

Paticipants with nomal BMI (18.5 - 24 kg/m2)

Diagnostic Test: health

Interventions

obesityDIAGNOSTIC_TEST

Patients diagnosed with obesity (BMI ≥ 28kg/m2)

the obesity group
healthDIAGNOSTIC_TEST

the health control group include paticipants with nomal BMI

the control group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This study intend to include patients diagnosed with obesity in the First Hospital of Chongqing Medical University.

You may qualify if:

  • Age ≥18 years;
  • Obese patients with BMI ≥30kg/m2;
  • Patients did not undergo surgical treatment before enrolment;
  • Willing to participate in this study and sign the informed consent form;
  • Complete clinical data.

You may not qualify if:

  • Patients with systemic diseases such as severe cardiorespiratory insufficiency that affect the choice of treatment regimen;
  • Pregnant or lactating women;
  • Patients who are not suitable for enrolment as assessed by the investigator;
  • Patients with incomplete clinical data.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital of Chongqing Medical University

Chongqing, Chongqing Municipality, 400016, China

Location

MeSH Terms

Conditions

ObesityOverweight

Interventions

Adiposity

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Body Fat DistributionBody Weights and MeasuresBody ConstitutionPhysical ExaminationDiagnostic Techniques and ProceduresDiagnosisBody CompositionBiochemical PhenomenaChemical PhenomenaMetabolismPhysiological Phenomena

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 2, 2024

First Posted

November 4, 2024

Study Start

October 1, 2022

Primary Completion

August 1, 2025

Study Completion

December 1, 2025

Last Updated

June 2, 2025

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

The Ethics Committee of this Clinical Centre does not allow the disclosure of patient information.

Locations